Modulation of inhibition of return by the dopamine D2 receptor agonist bromocriptine depends on individual DAT1 genotype

Ariel Rokem^*, Ayelet N. Landau, William Prinzmetal, Deanna L. Wallace, Michael A. Silver, Mark D'Esposito

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review